A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation

被引:42
作者
Neumann, S
Krause, G
Chey, S
Paschke, R
机构
[1] Univ Leipzig, Dept Med 3, D-04103 Leipzig, Germany
[2] Inst Mol Pharmacol, D-10315 Berlin, Germany
关键词
D O I
10.1210/me.15.8.1294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A specific H-bonding network formed between the central regions of transmembrane domain 6 and transmembrane domain 7 has been proposed to be critical for stabilizing the inactive state of glycoprotein hormone receptors. Many different constitutively activating TSH receptor point mutations have been identified in hyperfunctioning thyroid adenomas in the lower portion of transmembrane domain 6. Position D633 in transmembrane domain 6 of the human TSH receptor is the only one in which four different constitutively activating amino acid exchanges have been identified. Further in vitro substitutions led to constitutive activation of the TSH receptor (D633Y, F, C) as well as to the first inactivating TSH receptor mutation in transmembrane domain 6 without changes of membrane expression or TSH binding (D633R). Molecular modeling of this inactivating TSH receptor mutation revealed potential interaction partners of R633 in transmembrane domain 3 and/or transmembrane domain 7, presumably via hydrogen bonds that could be responsible for locking the TSH receptor in a completely inactive state. To further elucidate the H-bond network that most likely maintains the inactive state of the TSH receptor, we investigated these potential interactions by generating TSH receptor double mutants designed to break up possible H bonds. We excluded S508 in transmembrane domain 3 as a possible interaction partner of R633. In contrast, a partial response to TSH stimulation was rescued in a receptor construct with the double-substitution D633R/N674D. Our results therefore confirm the H bond between position 633 in transmembrane domain 6 and 674 in transmembrane domain 7 suggested by molecular modeling of the inactivating mutation D633R. Moreover, the mutagenesis results, together with a three-dimensional structure model, indicate that for TSH receptor activation and G protein-coupled signaling, at least one free available carboxylate oxygen is required as a hydrogen acceptor atom at position 674 in transmembrane domain 7.
引用
收藏
页码:1294 / 1305
页数:12
相关论文
共 53 条
[31]   Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas [J].
Russo, D ;
Arturi, F ;
Suarez, HG ;
Schlumberger, M ;
DuVillard, JA ;
Crocetti, U ;
Filetti, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (04) :1548-1551
[32]   PROJECTION STRUCTURE OF RHODOPSIN [J].
SCHERTLER, GFX ;
VILLA, C ;
HENDERSON, R .
NATURE, 1993, 362 (6422) :770-772
[33]   PROJECTION STRUCTURE OF FROG RHODOPSIN IN 2 CRYSTAL FORMS [J].
SCHERTLER, GFX ;
HARGRAVE, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11578-11582
[34]   Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide [J].
Schoneberg, T ;
Yun, JN ;
Wenkert, D ;
Wess, J .
EMBO JOURNAL, 1996, 15 (06) :1283-1291
[35]   THE LUTROPIN CHORIOGONADOTROPIN RECEPTOR ... 4 YEARS LATER [J].
SEGALOFF, DL ;
ASCOLI, M .
ENDOCRINE REVIEWS, 1993, 14 (03) :324-347
[36]   Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F [J].
Sheikh, SP ;
Zvyaga, TA ;
Lichtarge, O ;
Sakmar, TP ;
Bourne, HR .
NATURE, 1996, 383 (6598) :347-350
[37]   G PROTEIN-COUPLED RECEPTOR STRUCTURE AND FUNCTION - THE IMPACT OF DISEASE-CAUSING MUTATIONS [J].
SHENKER, A .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1995, 9 (03) :427-451
[38]   The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology [J].
Simoni, M ;
Gromoll, J ;
Nieschlag, E .
ENDOCRINE REVIEWS, 1997, 18 (06) :739-773
[39]   STRUCTURE AND FUNCTION OF G-PROTEIN-COUPLED RECEPTORS [J].
STRADER, CD ;
FONG, TM ;
TOTA, MR ;
UNDERWOOD, D ;
DIXON, RAF .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :101-132
[40]  
SWILLENS S, 1995, MOL PHARMACOL, V47, P1197